1-13 of 13
Ofrat Beyar Katz
Close
Sort by
Journal Articles

Second Vs Third Line Treatment with Axicabtagene Ciloleucel for Large B Cell Lymphoma - a Real-Life National Multicenter Retrospective Cohort Study with Propensity Score Matching

Gil Fridberg, Odelia Amit, Liat Shargian, Ofrat Beyar Katz, Sigal Grisariu, Chava Perry, Ronit Gurion, Batia Avni, Tsila Zuckerman, Irit Avivi Mazza, Ron Ram
Journal: Blood
Blood (2023) 142 (Supplement 1): 4886.
https://doi.org/10.1182/blood-2023-188473
Published: 2023
Journal Articles

CNS Prophylaxis in Diffuse Large B-Cell Lymphoma: A Common Toxic Clinical Practice Based on Abundant Opinion, Despite Evidence Suggesting Futility

Ofrat Beyar Katz, Shimrit Ringelstein-Harlev, Jacob M. Rowe
Journal: Blood
Blood (2023) 142 (Supplement 1): 7260.
https://doi.org/10.1182/blood-2023-178320
Published: 2023
Journal Articles

Response Rates of Extra-Nodal Diffuse Large B Cell Lymphoma to CD19-CAR T Cells - a Real Word Retrospective Multi-Center Study

Ofrat Beyar Katz, Chava Perry, Efrat Luttwak, Inbal Sdayoor, Yael Bar-On, Odelia Amit, Ronit Gold, Yair Herishanu, Noam Benyamini, Sigal Grisariu Greenzaid, Batia Avni, Polina Stepensky, Diana Libster, Dana Yehudai-Ofir, Shimrit Harlev, Liat Sharvit, Tsila Zuckerman, Uri Greenbaum, Irit Avivi, Ron Ram
Journal: Blood
Blood (2022) 140 (Supplement 1): 3816–3817.
https://doi.org/10.1182/blood-2022-165149
Published: 2022
Journal Articles

G-CSF Mobilized Apheresis As an Alternative Source of CAR T-Cells

Katherine D Cummins, Arjun Gupta, Ofrat Beyar-Katz, Ye Li, Paramita Chatterjee, Linda Kippner, Olga Shestova, Monika A Eiva, January Salas-Mckee, Carolyn Yeago, Krishnendu Roy, Saar Gill
Journal: Blood
Blood (2022) 140 (Supplement 1): 7415–7416.
https://doi.org/10.1182/blood-2022-165916
Published: 2022
Journal Articles

Sequential Therapy with Fitcy Preparative Regimen for Patients with Primary Refractory AML - a Single Center Retrospective Analysis

Odelia Amit, Yakir Moshe, Inna Ospovat, Yael Bar-On, Ofrat Beyar-Katz, Dina Tshernichovsy, Irit Avivi, Ron Ram
Journal: Blood
Blood (2021) 138 (Supplement 1): 2860.
https://doi.org/10.1182/blood-2021-152699
Published: 2021
Journal Articles

A Comprehensive Toxicity and Efficacy Analysis of Different Bridging Therapies Prior to Anti CD19-CAR-T Cell Therapy in Patients with DLBCL- a National Multi-Center Cohort Study

Ron Ram, Sigal Grisariu, Liat Shargian-Alon, Dana Yehudai-Ofir, Irit Avivi, Orit Gutfeld, Polina Stepensky, Tsila Zuckerman, Moshe Yeshurun, Odelia Amit, Batia Avni, Ronit Gurion, Yael Bar-On, Ofrat Beyar-Katz, Ronit Gold, Shimrit Ringelstein, Itai Levi, Tzvi Porges, Chava Perry
Journal: Blood
Blood (2021) 138 (Supplement 1): 1733.
https://doi.org/10.1182/blood-2021-151085
Published: 2021
Journal Articles

Antibiotic Stewardship in Patients after Cellular Therapy with Febrile Neutropenia- a Single Center Prospective Unblinded Randomized Trial

Ron Ram, Odelia Amit, Amos Adler, Yael Bar-On, Ofrat Beyar-Katz, Irit Avivi, David Shasha, Ronen Ben-Ami
Journal: Blood
Blood (2021) 138 (Supplement 1): 747.
https://doi.org/10.1182/blood-2021-152559
Published: 2021
Journal Articles

Daratumumab in Combination with Vincristine or Nelarabine As Effective Salvage Therapy for Patients with Acute Lymphoblastic Leukemia at High Risk of Relapse

Yishai Ofran, MD, Chezi Ganzel, MD, Shimrit Harlev, MD PhD, Ilana Slouzkey, PhD, Ofrat Beyar Katz, MD, Michal Hayun, PhD, Mira Kharit, MD, Jacob M. Rowe, MD, Avraham Frisch, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5206.
https://doi.org/10.1182/blood-2018-99-111258
Published: 2018
Journal Articles

Bortezomib-Activated Macrophages Contribute to Multiple Myeloma Progression Via Cancer Stem Cell Enrichment

Ofrat Beyar Katz, MD, Ksenia Magidey Klein, M.Sc, Michael Timaner, PhD, Ziv Raviv, PhD, Noam Benyamini, MD, Benjamin Brenner, MD, Yuval Shaked, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2269.
https://doi.org/10.1182/blood.V130.Suppl_1.2269.2269
Published: 2017
Journal Articles

Published abstracts at international meetings often over- or underestimate the initial response rate

Clinical Trials & Observations
Ofrat Beyar-Katz, Jacob M. Rowe, Lauren E. Townsend, Martin S. Tallman, Rivka Hadomi, Netanel A. Horowitz
Journal: Blood
Blood (2017) 129 (16): 2326–2328.
https://doi.org/10.1182/blood-2017-01-763144
Published: 2017
Includes: Supplemental data
Journal Articles

Autologous Stem Cell Transplantation in Favorable Acute Myeloid Leukemia Is Associated with a Better Long-Term Prognosis: a Single Center Experience

Ofrat Beyar-Katz, MD, Israel Henig, MD, Dana Yehudai, MD, Nov Yuval, MSc, Riva Fineman, MD, Nuhad Haddad, MD, Yishai Ofran, MD, Jacob M. Rowe, MD, Tsila Zuckerman, MD
Journal: Blood
Blood (2016) 128 (22): 5819.
https://doi.org/10.1182/blood.V128.22.5819.5819
Published: 2016
Journal Articles

Bortezomib-Induced Proinflammatory Macrophages Contribute to Multiple Myeloma Cell Aggressiveness

Ofrat Beyar Katz, MD, Neta Ben-Tsedek, Irit Avivi, MD, Dror Alishekevitz, Michael Timaner, Valeria Miller, Moshit Lindzen, Yosef Yarden, Yuval Shaked
Journal: Blood
Blood (2015) 126 (23): 5367.
https://doi.org/10.1182/blood.V126.23.5367.5367
Published: 2015
Journal Articles

Immature Platelet Fraction Predicts Outcome and Sepsis Development in Critically Ill Patients Admitted to a General Intensive Care Unit, but Not in Neutropenic Patients

Doaa Okasha, MD, Galit Sarig, PhD, Noam Benyamini, MD, Ronit Tamir, PhD, Ofrat Beyar Katz, MD, Lena Markuze, MSc, Marielle Kaplan, PhD, Yishai Ofran, MD
Journal: Blood
Blood (2014) 124 (21): 2164.
https://doi.org/10.1182/blood.V124.21.2164.2164
Published: 2014